High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes

Experimental Eye Research

Volumn 82, Issue 1, 2006, Pages 172-178

  Matsuoka, Masato ^a   Ogata, Nahoko ^a   Minamino, Keizo ^a   Higuchi, Akiko ^a   Matsumura, Miyo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGE); Angiogenesis; Diabetes mellitus; Diabetic retinopathy; Pigment epithelium derived factor (PEDF); Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENESIS MODULATOR; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HISTOPATHOLOGY; IMMUNOREACTIVITY; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; RETINA ANGIOGRAPHY; RETINA NEOVASCULARIZATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EYE PROTEINS; FLUORESCEIN ANGIOGRAPHY; GLYCOSYLATION END PRODUCTS, ADVANCED; MODELS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; RATS; RATS, MUTANT STRAINS; RETINA; SERPINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 30344469077     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.05.011     Document Type: Article

References (25)

1. A.P. Adamis, J.W. Miller, M.T. Bernal, D.J. D'Amico, J. Folkman, T.K. Yeo, and K.T. Yeo Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am. J. Ophthalmol. 118 1994 445 450
2. L.P. Aiello, R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, S.T. Shah, L.R. Pasquale, H. Thieme, M.A. Iwamoto, and J.E. Park Vascular endothelial growth factor in ocular fluid of patients with proliferative diabetic retinopathy and ocular retinal disorders N. Engl. J. Med. 331 1994 1480 1487
3. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1321
4. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H. Xu, W. Benedict, and N.P. Bouck Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 1999 245 248
5. G. Gao, Y. Li, D. Zhang, S. Gee, C. Crosson, and J-X. Ma Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularizarion FEBS Lett. 489 2001 270 276
6. G. Gao, Y. Li, C.E. Crosson, S.P. Becerra, and J-X. Ma Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in Brown-Norway and Sprague dawley rats contributing to different susceptibility to retinal neovascularization Diabetes 51 2002 1218 1225
7. G. Gao, Y. Li, S. Gee, A. Dudley, J. Fant, C. Crosson, and J-X. Ma Down-regulation of VEGF and up-regulation of PEDF: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5 J. Biol. Chem. 277 2002 9492 9497
8. H.P. Hammes, J. Lin, R.G. Bretzel, M. Brownlee, and G. Breier Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat Diabetes 47 1998 401 406
9. Y. Inagaki, S. Yamagishi, T. Okamoto, M. Takeuchi, and S. Amano Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 productio in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation Diabetologia 46 2003 284 287
10. S. Isida, K. Shinoda, S. Kawashima, Y. Oguchi, Y. Okada, and E. Ikeda Coexpression of VEGF receptors VEGF-R2 and Neurophilin-1 in proliferative diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 41 2000 1649 1656
11. R.A. Linsenmeier, R.D. Braun, M.A. McRipley, L.B. Padnick, J. Ahmed, D.L. Hatchell, D.S. McLeod, and G.A. Lutty Retinal hypoxia in long-term diabetic cats Invest. Ophthalmol. Vis. Sci. 39 1998 1647 1657
12. T. Masuyama, M. Fuse, N. Yokoi, M. Shinohara, H. Tsuji, M. kanazawa, Y. Kanazawa, K. Komeda, and K. Taniguchi Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rats Biochem. Biophy. Res. Commun. 304 2003 196 206
13. N. Ogata, J. Tombran-Tink, M. Nishikawa, T. Nishimura, Y. Mitsuma, D. Mrazek, T. Sakamoto, and M. Matsumura Pigment epithelium derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment Am. J. Ophthalmol. 132 2001 378 382
14. N. Ogata, M. Nishikawa, T. Nishimura, Y. Mitsuma, and M. Matsumura Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy Am. J. Ophthalmol. 134 2002 348 353
15. J. Pe'er, R. Folberg, A. Itin, H. Gnessin, I. Hemo, and E. Keshet Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy Br. J. Ophthalmol. 80 1996 241 245
16. M. Shinohara, T. Masuyama, T. Shoda, Y. Katsuda, K. Komeda, M. Kuroki, A. Kakehashi, and Y. Kanazawa A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications Int. J. Exp. Diabetic Res. 1 2000 89 100
17. A.A.F. Sima, S. Chakrabatri, R. Garcia-Salinas, and P.K. Basu The BB-rat- an authentic model of human diabetic retinopathy Curr. Eye Res. 4 1985 1087 1092
18. J. Spranger, M. Osterhoff, M. Reimann, M. Mohlig, M. Ristow, M.K. Francis, V. Cristofalo, H.P. Hammes, G. Smith, M. Boulton, and A.F. Pfeiffer Loss of antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye diseases Diabetes 50 2001 2641 2645
19. V. Stellmach, S.E. Crawford, W. Zhou, and N. Bouck Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor Proc. Natl Acad. Soc. USA 98 2001 2593 2597
20. R.G. Tilton, L.S. LaRose, C. Kilo, and J.R. Williamson Absence of degenerative changes in retinal uveal capillary pericytes in diabetic rats Invest. Ophthalmol. Vis. Sci. 27 1986 716 721
21. C. Treins, S. Giorgetti-Peraldl, J. Murdaca, and E. Obberghen Regulation of vascular endothelial growth factor expression by advanced glycation end products J. Biol. Chem. 276 2001 43836 43841
22. H. Vlassara, H. Fuh, T. Donnelly, and M. Cybulsky Advanced glycation endproducts promote adhesion molecules (VCAM-1, IVAM-1) expression and atheroma formation in normal rabbits Mol. Med. 1 1995 447 456
23. S. Yamagishi, H. Yonekura, Y. Yamamoto, K. Katsuno, F. Sato, I. Mita, H. Ooka, K. Satozawa, T. Kawakami, M. Nomura, and H. Yamamoto Advanced glycation end products-driven angiogenesis in vitro J. Biol. Chem. 272 1997 8723 8730
24. S. Yamagishi, Y. Amano, Y. Inagaki, T. Okamoto, N. Koga, N. Sasaki, C. Hsu, M. Taniguchi, S. Harada, H. Yamamoto, M. Takeuchi, and Z. Makita Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth in bovine retinal pericytes Biochem. Biophys. Res. Commun. 290 2002 973 978
25. S. Yamagishi, Y. Inagaki, S. Amano, T. Okamoto, M. Takeuchi, and Z. Makita Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochem. Biophy. Res. Commun. 296 2002 877 882